We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
-2.8%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$1.22B
AUM Growth
-$44.8M
Cap. Flow
+$3.01M
Cap. Flow %
0.25%
Top 10 Hldgs %
29.85%
Holding
194
New
3
Increased
55
Reduced
48
Closed
9

Top Buys

Rank Stock Value
1
PPLI
People Inc
PPLI
+$950K
2
CB icon
Chubb
CB
+$761K
3
BLKB icon
Blackbaud
BLKB
+$689K
4
HXL icon
Hexcel
HXL
+$638K
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$628K

Top Sells

Rank Stock Value
1
BC icon
Brunswick
BC
+$1.84M
2
FDX icon
FedEx
FDX
+$1.8M
3
MSFT icon
Microsoft
MSFT
+$1.69M
4
SNPS icon
Synopsys
SNPS
+$1.41M
5
AAPL icon
Apple
AAPL
+$727K

Sector Composition

Rank Sector Weight
1 Technology 27.18%
2 Healthcare 16.06%
3 Industrials 11.8%
4 Financials 11.68%
5 Consumer Staples 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
USB icon
26
US Bancorp
USB
$97.9B
$18.2M 1.48%
450,632
+10,943
+2% +$506K
TRMB icon
27
Trimble
TRMB
$13.6B
$18M 1.47%
331,069
+5,772
+2% +$365K
DVN icon
28
Devon Energy
DVN
$51.3B
$17.9M 1.46%
297,356
-3,048
-1% -$189K
MDT icon
29
Medtronic
MDT
$112B
$17.7M 1.44%
218,858
-1,831
-0.8% -$165K
AMAT icon
30
Applied Materials
AMAT
$347B
$17.7M 1.44%
215,512
-24
-0% -$2.31K
WY icon
31
Weyerhaeuser
WY
$17.6B
$17.5M 1.43%
611,418
+5,798
+1% +$197K
JNJ icon
32
Johnson & Johnson
JNJ
$640B
$17.3M 1.41%
105,834
-957
-0.9% -$162K
DIS icon
33
Walt Disney
DIS
$171B
$17.2M 1.41%
182,502
+3,874
+2% +$415K
GILD icon
34
Gilead Sciences
GILD
$165B
$16.8M 1.37%
272,248
+8,485
+3% +$535K
HXL icon
35
Hexcel
HXL
$7.97B
$16.2M 1.32%
313,343
+10,962
+4% +$638K
PG icon
36
Procter & Gamble
PG
$340B
$15.4M 1.26%
122,102
+70
+0.1% +$9.94K
AAPL icon
37
Apple
AAPL
$4.97T
$14.2M 1.16%
102,842
-4,629
-4% -$727K
XOM icon
38
ExxonMobil
XOM
$650B
$13.8M 1.13%
158,270
-2,002
-1% -$183K
PPG icon
39
PPG Industries
PPG
$24.9B
$13.5M 1.1%
121,872
+490
+0.4% +$60.6K
ZBH icon
40
Zimmer Biomet
ZBH
$18.8B
$13.4M 1.09%
127,927
-1,397
-1% -$153K
SNY icon
41
Sanofi
SNY
$107B
$12.9M 1.05%
339,926
+1,326
+0.4% +$59.1K
WLY icon
42
John Wiley & Sons Class A
WLY
$2.83B
$12.6M 1.03%
335,051
+12,909
+4% +$613K
SHEL icon
43
Shell
SHEL
$244B
$12.2M 0.99%
244,206
+5,110
+2% +$263K
TMO icon
44
Thermo Fisher Scientific
TMO
$214B
$10.9M 0.89%
21,465
+600
+3% +$336K
CTSH icon
45
Cognizant
CTSH
$25.2B
$10.7M 0.88%
187,048
+3,373
+2% +$221K
GLW icon
46
Corning
GLW
$107B
$10.6M 0.86%
364,503
+2,117
+0.6% +$71.7K
NVS icon
47
Novartis
NVS
$302B
$10.6M 0.86%
139,203
+1,734
+1% +$144K
AZO icon
48
AutoZone
AZO
$51.3B
$9.79M 0.8%
4,569
+189
+4% +$412K
BRK.A icon
49
Berkshire Hathaway Class A
BRK.A
$1.1T
$8.13M 0.66%
20
– –
TDY icon
50
Teledyne Technologies
TDY
$29.2B
$7.57M 0.62%
22,423
+1,219
+6% +$465K
1
2
3 4 5

Similar funds

HHAM
HITE Hedge Asset Management Braintree, Massachusetts $1.77B AUM 38.67% 1-Year Est. Return
FFS
Founders Financial Securities Towson, Maryland $1.77B AUM 17.63% 1-Year Est. Return
KOCAA
Knights of Columbus Asset Advisors New Haven, Connecticut $1.77B AUM 31.28% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
SW
Simplicity Wealth Summit, New Jersey $1.76B AUM 20.49% 1-Year Est. Return
BCMIO
Beacon Capital Management Inc (Ohio) Dayton, Ohio $1.78B AUM 14.7% 1-Year Est. Return
UF
Univest Financial Souderton, Pennsylvania $1.78B AUM 22.52% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return

Grandfield & Dodd's Q3 2022 Portfolio in Review

As of Q3 2022, Grandfield & Dodd held 194 positions worth $1.22B, down 3.5% from $1.27B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Grandfield & Dodd's Q3 2022 filing shows 3 new, 55 increased, 48 reduced and 9 closed positions. Its largest new stake was Genmab: 10,210 shares worth $330K. The largest sale was Brunswick, an estimated $1.84M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Industrials.

  • Grandfield & Dodd's largest Q3 2022 buy was Genmab: 10,210 shares worth $330K.
  • Grandfield & Dodd added most to People Inc in Q3 2022, an estimated $950K increase.
  • Grandfield & Dodd's biggest Q3 2022 reduction was Brunswick, cutting an estimated $1.84M.
  • Grandfield & Dodd fully exited Verizon in Q3 2022, selling an estimated $420K.
  • Grandfield & Dodd's ten largest holdings make up 30% of its $1.22B portfolio in Q3 2022.
  • Grandfield & Dodd opened 3 new positions and closed 9 in Q3 2022.
  • Grandfield & Dodd's portfolio value fell 3.5% quarter-over-quarter to $1.22B.

Based on Grandfield & Dodd's 13F filing for Q3 2022, filed 4 Nov 2022.